Status:
COMPLETED
Local Recurrence Prediction of by Texture Analysis Derived From Positron Emission Tomography (PET / CT) Imaging of Non-small Cell Lung Cancer (NSCLC) Treated With Stereotactic Radiotherapy (SBRT) (Retros MUMOFRAT)
Lead Sponsor:
University Hospital, Brest
Conditions:
Identify FDG PET/CT Parameters Predictive of Local Control
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this retrospective multicentric study was to develop and evaluate a prognostic FDG PET/CT radiomics signature in early-stage non-small cell lung cancer (NSCLC) patients treated with stereot...
Eligibility Criteria
Inclusion
- NSCLC stage I-II treated by SBRT
- PET/CT imaging performed within 60 days of SBRT
Exclusion
- Lack of follow-up
- Refusal of consent
Key Trial Info
Start Date :
January 7 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 6 2019
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT06555861
Start Date
January 7 2019
End Date
February 6 2019
Last Update
August 15 2024
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
ICO
Nantes, Saint Herblain, France, 44800
2
CHRU de Brest
Brest, France, 29609
3
Centre Eugènes Marquis
Rennes, France, 35042
4
CHU de Tours
Tours, France, 37000